The Patent Finder

Cormedix Inc.

7 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Aug 2036
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 28, 2027
    The maintenance fee for Synthesis of Taurolidine, Purity Profiles and Polymorphs (US 11,738,120) comes due Feb 28, 2027. Unpaid by Aug 30, 2027, it lapses early.
  • 1 fee due May 19, 2027
    The maintenance fee for Field Sterilizer and Vascular Connector Kit (US 10,478,640) comes due May 19, 2027. Unpaid by Nov 19, 2027, it lapses early.
  • 1 fee due Jun 30, 2027
    The maintenance fee for Antimicrobial Wound Closure Materials, Including Antimicrobial Sutures, and Method for Closing a Wound Using the Same (US 10,517,984) comes due Jun 30, 2027. Unpaid by Jan 3, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 7 of 7

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,517,984Antimicrobial Wound Closure Materials, Including Antimicrobial Sutures, and Method for Closing a Wound Using the Same
In force
 · High confidence
In forceHigh confidence
US 11,541,061Neuroblastoma Treatment with Taurolidine Hydrolysis Products
In force
 · High confidence
In forceHigh confidence
US 12,053,478Taurultam, Taurinamide and Methylene Glycol Treatment for Myc-Expressing Tumors in Mammalian Bodies
In force
 · Low confidence
In forceLow confidence
US 10,478,640Field Sterilizer and Vascular Connector Kit
In force
 · High confidence
In forceHigh confidence
US 12,302,902Antimicrobial Compositions, Including Antimicrobial Hydrogels, Effective Against Mature Biofilms
In force
 · High confidence
In forceHigh confidence
US 12,016,865Methods and pharmaceutical compositions for treating candida auris in blood
In force
 · USPTO record
In forceUSPTO record
US 11,738,120Synthesis of Taurolidine, Purity Profiles and Polymorphs
In force
 · High confidence
In forceHigh confidence

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

7 pending · 12 abandoned · 4 no status recorded

Showing 1 to 10 of 23, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
19/212,911Antimicrobial Compositions, Including Antimicrobial Hydrogels, Effective Against Mature BiofilmsMay 20, 2025Pending
18/795,424Taurolidine Treatment for Myc-Expressing Tumors in Mammalian BodiesAug 6, 2024Pending
18/753,035Methods and Pharmaceutical Compositions for Treating Candida Auris in BloodJun 25, 2024Pending
18/856,087Improved Synthesis of Taurolidine, Purity Profiles and PolymorphsApr 14, 2023Pending
18/091,504Neuroblastoma Treatment with Taurolidine Hydrolysis ProductsDec 30, 2022Pending
17/705,699Therapeutic Nanoparticles for the Treatment of Neuroblastoma and Other CancersMar 28, 2022Pending
17/675,639Skin-Penetrating Formulation of TaurolidineFeb 18, 2022Abandoned
17/530,138Methods and Compositions for Treating Neuroblastoma in a Juvenile Mammalian BodyNov 18, 2021Pending
17/063,142Oct 5, 2020No status recorded
16/878,057Skin-Penetrating Formulation of TaurolidineMay 19, 2020Abandoned
10 of 23 applications shown.
Pro members see all 23 published applications.
Pro members: see all 23 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited